Apple Inc. is reportedly planning a full redesign for the Apple Watch Ultra 4 alongside a new high-blood-pressure monitoring feature [1].
These updates represent a significant shift for the Ultra line, moving from incremental updates to a major hardware refresh aimed at improving battery life and performance [3]. The addition of hypertension alerts would position the device as a more robust medical tool for users monitoring cardiovascular health [1].
The rumored blood pressure feature uses the device's optical heart-rate sensor to identify high blood pressure and provide notifications [2]. This specific functionality is currently under review by the U.S. Food and Drug Administration [2]. According to reports, these hypertension notifications were introduced with watchOS 26 [1].
Beyond health sensors, the Ultra 4 is expected to undergo its first major physical redesign [3]. Some reports indicate the new model will double its current number of sensors [3]. This expansion of hardware capabilities is intended to broaden the device's overall health-monitoring utility, while addressing long-standing performance concerns [3].
Apple has not officially confirmed these specifications. However, the new hardware and software features are expected to arrive during the company's launch season in fall 2026 [2].
“The upcoming Apple Watch Ultra 4 is rumored to receive a full redesign.”
By integrating blood pressure monitoring and a hardware overhaul, Apple is attempting to transition the Watch Ultra from a rugged sports accessory into a critical health-diagnostic tool. Success depends on FDA approval and the accuracy of optical sensor-based monitoring, which is historically more challenging than traditional cuff-based measurements.
